TATE Share Price Performance
UK£0
-7.33 (-100.00%)
Price UK£0
Fair ValueUK£5.90
Share Pricen/a
Tate & Lyle (LON:TATE) Has Announced A Dividend Of £0.066
Nov 09
Tate & Lyle plc Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 51 Fair Values set on narratives written by author
TATE Community Narratives
AN
Fair Value UK£5.9 37.7% undervalued intrinsic discount
Regulatory And Integration Hurdles Will Constrain Upside But Spur Revaluation
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value UK£5.14 28.5% undervalued intrinsic discount
TATE: Revenue Guidance Revisions Will Drive Near-Term Re-Rating Opportunity
2users have liked this narrative
0users have commented on this narrative
35users have followed this narrative
AN
Fair Value UK£8.2 55.2% undervalued intrinsic discount
Rising Health Trends And Urbanization Will Expand Specialty Markets
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
TATE: Revenue Guidance Revisions Will Drive Near-Term Re-Rating Opportunity
Key Takeaways Expansion through CP Kelco enhances specialty solutions, driving revenue growth and improving profitability via anticipated cost synergies and EBITDA margin uplift. Strong cash flow and disciplined financial management fuel share buybacks, increasing EPS, while innovation drives new revenue streams and strengthens market position.Read more
2users have liked this narrative
0users have commented on this narrative
35users have followed this narrative
AN
UK£5.14
28.5% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
3.38% p.a.
Profit Margin
9.35%
Future PE
16.66x
Share price in 2028
UK£6.31
Regulatory And Integration Hurdles Will Constrain Upside But Spur Revaluation
Key Takeaways Integration challenges, rising compliance costs, and volatile supply chains may delay expected growth and put sustained pressure on margins and earnings momentum. Slower innovation uptake, regulatory risks, and uneven global demand could constrain revenue acceleration and postpone stronger company valuation.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
UK£5.9
37.7% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
9.96% p.a.
Profit Margin
10.25%
Future PE
16.45x
Share price in 2028
UK£7.19
Rising Health Trends And Urbanization Will Expand Specialty Markets
Key Takeaways Synergy gains, innovation-driven specialty revenue growth, and superior solution-selling could significantly boost margins, operating leverage, and earnings beyond current expectations. Expansion in emerging markets and rising global demand for healthier food ingredients position Tate & Lyle for long-term revenue gains and increased pricing power.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
UK£8.2
55.2% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
12.44% p.a.
Profit Margin
11.56%
Future PE
18.96x
Share price in 2028
UK£9.99
Recently Updated Narratives
AN
TATE: Revenue Guidance Revisions Will Drive Near-Term Re-Rating Opportunity
Fair Value: UK£5.14 28.5% undervalued intrinsic discount
35 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Regulatory And Integration Hurdles Will Constrain Upside But Spur Revaluation
Fair Value: UK£5.9 37.7% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Health Trends And Urbanization Will Expand Specialty Markets
Fair Value: UK£8.2 55.2% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Tate & Lyle plc Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
May 21, 2026
- 0.077
- 58.44%
- 1.71%
- 79.4%
About TATE
- Founded
- 1903
- Employees
- 5000
- CEO
- WebsiteView website
Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. The company operates through four segments: Food & Beverage Solutions, Sucralose, Primary Products Europe, and CP Kelco. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company’s products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
